Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-01-13

Clinical Trial Update: A Bioequivalence Study Comparing Cilnidipine/Valsartan Combination With Coadministration of Cilnidipine and Valsartan [Phase 1]

View source ↗

Summary

Phase 1 bioequivalence study evaluating a Cilnidipine/Valsartan fixed-dose combination versus coadministration of Cilnidipine and Valsartan; study completed in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cilnidipine (cilnidipine)
  • Cilnidipine/Valsartan fixed-dose combination (cilnidipine/valsartan)
  • VALSARTAN (Valsartan)

Snippet

Sponsor: IlDong Pharmaceutical Co Ltd | Conditions: Hypertension | Phase 1 | Status: COMPLETED